New biomarkers for Alzheimer's disease, depression and beyond
Newly developed biomarkers may enhance clinicians' ability to detect and treat disorders of the nervous system, including Alzheimer's disease, mood disorders and neurodevelopmental conditions. The findings were presented at Neuroscience 2026, the annual meeting of the Society for Neuroscience.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Commerce Department under pressure for delaying export controls on Nvidia chips
United States
-
Couple with Autism and ADHD Find Passion Cleaning Filthy Street Signs
United Kingdom
-
ADHD's effects on breathing, perception and behavior
United Kingdom
-
Using AI to accelerate neuroscience research
United Kingdom
-
Sex differences in pain, inflammation and Alzheimer's disease
United Kingdom
-
Brain-computer interfaces: A new voice for people with paralysis
United Kingdom
-
New brain-body connections expand understanding of Alzheimer's disease
United Kingdom
-
A single CRISPR infusion lowers blood fats in monkeys for three years
United Kingdom